Single-molecule imaging reveals Aβ42:Aβ40 ratio-dependent oligomer growth on neuronal processes

Biophysical Journal

Volumn 104, Issue 4, 2013, Pages 894-903

  Johnson, Robin D ^a,d   Schauerte, Joseph A ^a   Chang, Chun Chieh ^a   Wisser, Kathleen C ^a   Althaus, John Christian ^b   Carruthers, Cynthia J L ^b   Sutton, Michael A ^b,c   Steel, Duncan G ^a   Gafni, Ari ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d 930 N University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; HIPPOCAMPUS; INTRACELLULAR MEMBRANE; METABOLISM; NEURITE; PROTEIN MULTIMERIZATION; PROTEIN SUBUNIT; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL MEMBRANE; HIPPOCAMPUS; INTRACELLULAR MEMBRANES; MICROSCOPY, FLUORESCENCE; NEURITES; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; RATS;

EID: 84874130800     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2012.12.051     Document Type: Article

References (45)

1. Alzheimer's Association 2012 Alzheimer's disease facts and figures Alzheimers Dement. 8 2012 131 168
2. W.L. Klein Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets Neurochem. Int. 41 2002 345 352
3. P.J. Crouch, and S.-M.E. Harding C.L. Masters Mechanisms of A β mediated neurodegeneration in Alzheimer's disease Int. J. Biochem. Cell Biol. 40 2008 181 198
4. J.-T. Yu, R.C.-C. Chang, and L. Tan Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities Prog. Neurobiol. 89 2009 240 255
5. C.A. McLean, and R.A. Cherny C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
6. L.F. Lue, and Y.M. Kuo J. Rogers Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
7. G. Bitan, and M.D. Kirkitadze D.B. Teplow Amyloid β-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways Proc. Natl. Acad. Sci. USA 100 2003 330 335
8. G. Bitan, A. Lomakin, and D.B. Teplow Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins J. Biol. Chem. 276 2001 35176 35184
9. H. Ding, and P.T. Wong D.G. Steel Determination of the oligomer size of amyloidogenic protein β-amyloid(1-40) by single-molecule spectroscopy Biophys. J. 97 2009 912 921
10. G. Lee, H.B. Pollard, and N. Arispe Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid-β-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site Peptides 23 2002 1249 1263
11. O. Simakova, and N.J. Arispe The cell-selective neurotoxicity of the Alzheimer's Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity J. Neurosci. 27 2007 13719 13729
12. R. Williamson, and A. Usardi B.H. Anderton Membrane-bound β-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism FASEB J. 22 2008 1552 1559
13. M. Zampagni, and E. Evangelisti C. Cecchi Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane J. Mol. Med. 88 2010 597 608
14. A.M. Nicholson, and A. Ferreira Increased membrane cholesterol might render mature hippocampal neurons more susceptible to β-amyloid-induced calpain activation and tau toxicity J. Neurosci. 29 2009 4640 4651
15. D.A. Bateman, J. McLaurin, and A. Chakrabartty Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding BMC Neurosci. 8 2007 29
16. H.Y. Wang, and D.H. Lee A.B. Reitz β-Amyloid(1-42) binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology J. Biol. Chem. 275 2000 5626 5632
17. J. Laurén, and D.A. Gimbel S.M. Strittmatter Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers Nature 457 2009 1128 1132
18. M. Renner, and P.N. Lacor A. Triller Deleterious effects of amyloid β oligomers acting as an extracellular scaffold for mGluR5 Neuron 66 2010 739 754
19. M. Cissé, and B. Halabisky L. Mucke Reversing EphB2 depletion rescues cognitive functions in Alzheimer model Nature 469 2011 47 52
20. I. Benilova, E. Karran, and B. De Strooper The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes Nat. Neurosci. 15 2012 349 357
21. K.N. Dahlgren, and A.M. Manelli M.J. LaDu Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
22. A. Demuro, and E. Mina C.G. Glabe Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers J. Biol. Chem. 280 2005 17294 17300
23. N. Arispe, H.B. Pollard, and E. Rojas Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes Proc. Natl. Acad. Sci. USA 90 1993 10573 10577
24. M. Kawahara, and N. Arispe E. Rojas Alzheimer's disease amyloid β-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons Biophys. J. 73 1997 67 75
25. Y.-J. Zhang, and J.-M. Shi S.R. Ji Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay J. Biol. Chem. 287 2012 748 756
26. G.M. Shankar, and S. Li D.J. Selkoe Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
27. R.D. Johnson, and J.A. Schauerte D.G. Steel Direct observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrations PLoS ONE 6 2011 e23970
28. J.A. Schauerte, and P.T. Wong A. Gafni Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers Biochemistry 49 2010 3031 3039
29. S.K. Jakawich, and H.B. Nasser M.A. Sutton Local presynaptic activity gates homeostatic changes in presynaptic function driven by dendritic BDNF synthesis Neuron 68 2010 1143 1158
30. P.N. Lacor, and M.C. Buniel W.L. Klein Synaptic targeting by Alzheimer's-related amyloid β oligomers J. Neurosci. 24 2004 10191 10200
31. R.M. Koffie, and M. Meyer-Luehmann T.L. Spires-Jones Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques Proc. Natl. Acad. Sci. USA 106 2009 4012 4017
32. D.A. Mitrano, and Y. Smith Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey J. Comp. Neurol. 500 2007 788 806
33. G.E. Hardingham, and H. Bading Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders Nat. Rev. Neurosci. 11 2010 682 696
34. M. Calamai, and F.S. Pavone Single molecule tracking analysis reveals that the surface mobility of amyloid oligomers is driven by their conformational structure J. Am. Chem. Soc. 133 2011 12001 12008
35. K. Duff, and C. Eckman S. Younkin Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 Nature 383 1996 710 713
36. M. Citron, and D. Westaway D.J. Selkoe Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice Nat. Med. 3 1997 67 72
37. D.R. Borchelt, and G. Thinakaran S.S. Sisodia Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
38. S. Kumar-Singh, and J. Theuns C. Van Broeckhoven Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40 Hum. Mutat. 27 2006 686 695
39. E.S. Walker, and M. Martinez A. Goate Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios J. Neurochem. 92 2005 294 301
40. M. Murray, and S. Bernstein M.T. Bowers Amyloid β protein: Aβ40 inhibits Aβ42 oligomerization J. Am. Chem. Soc. 313 2009 6316 6317
41. K. Pauwels, and T.L. Williams K. Broersen Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease J. Biol. Chem. 287 2012 5650 5660
42. A. Jan, and O. Gokce H.A. Lashuel The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity J. Biol. Chem. 283 2008 28176 28189
43. I. Kuperstein, and K. Broersen B. De Strooper Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio EMBO J. 29 2010 3408 3420
44. K. Ono, M.M. Condron, and D.B. Teplow Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc. Natl. Acad. Sci. USA 106 2009 14745 14750
45. B. O'Nuallain, and D.B. Freir D.M. Walsh Amyloid β-protein dimers rapidly form stable synaptotoxic protofibrils J. Neurosci. 30 2010 14411 14419